baber/WOPTO huggingface dataset:
Patent NZ-591921-A (NZ)
Title: Targeted contact and vibration stimulation apparatus for the penis to delay ejactulation
Inventor: ZAMAR ANTONIOS CAMILLE
IPC: A61F5/41
Filed: 2009-09-03
Abstract: 591921 Disclosed is an apparatus (1) for applying targeted stimulation at or adjacent the base of the area of the glans of the penis to provide an overall desenistising or tolerising effect towards other stimulation effects. The apparatus comprises a contact portion having a first contact surface (3) conforming substantially to the longitudinal profile of the penis, the contact portion further having a second contact surface (4), raised, in use, inwardly of the first contact surface towards the penis, to project in use into positive engagement with the area at or adjacent the base of the glans of the penis. The second contact surface has an arcuate profile or a domed configuration. The first and second contact surfaces and side wings have a plurality of protrusions.
Patent NZ-592701-A (NZ)
Title: Manipulator for bucket or pail with hand or wrist connection to cause connecting part, as handle or handle attachment, to rotate relative to bucket body
Inventor: ALLAN DONALD BRYCE
IPC: A47J47/18
Filed: 2011-05-06
Abstract: A manipulator 1 is attachable irrotationally to a handle 2 of a bucket or pail 3 at a connection portion 4, and has a leverage portion 5 which in use abuts a portion of an operator's hand or wrist. This allows a rotational force to be applied at or near the connection portion 4 to result in the handle being rotated away from an open end of the bucket.
Patent NZ-592897-A (NZ)
Title: Crystals of laquinimod sodium, and process for the manufacture thereof
Inventor: FRENKEL ANTON
IPC: C07D215/22
Filed: 2006-10-18
Abstract: Disclosed and claimed is Laquinimod sodium, which has been recrystallised, and which may be in any suitable crystalline form.
Patent NZ-593104-A (NZ)
Title: P38 map kinase inhibitors
Inventor: ITO KAZUHIRO
IPC: A61K31/415
Filed: 2009-12-11
Abstract: Disclosed herein are pyrazol-pyridine compounds of formula (IA), wherein the substituents are as defined within the specification; processes for its preparation, compositions comprising said compounds and uses thereof. Said compounds ar useful as inhibitors of p38 mitogen-activated protein kinase enzymes (p38 MAP kinase inhibitors), particularly the alpha and gamma kinase sub-types thereof and as such is useful in the treatment of COPD, chronic bronchitis, emphysema, asthma, paediatric asthma, cystic fibrosis, sarcoidosis, idiopathic pulmonary fibrosis, allergic rhinitis, rhinitis, sinusitis, allergic conjunctivitis, conjunctivitis, allergic dermatitis, contact dermatitis, psoriasis, ulcerative colitis, inflamed joints secondary to rheumatoid arthritis or osteoarthritis, rheumatoid arthritis, pancreatitis, cachexia, inhibition of the growth and metastasis of tumours including non-small cell lung carcinoma, breast carcinoma, gastric carcinoma, colorectal carcinomas and malignant melanoma. Specifically preferred examples include: · N-(4-(2-(4-(3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yl)ethoxy)pyridin-2-yl)-2-methoxyacetamide; · N-(4-(1-(4-(3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)ethyl)pyridin-2-yl)-2-methoxyacetamide; · N-(4-(2-(4-(3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)-2-methylpropyl)pyridin-2-yl)-2-methoxyacetamide; · N-(4-(2-(4-(3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)propyl)pyridin-2-yl)-2-methoxyacetamide; · N-(4-(1-(4-(3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)propan-2-yl)pyridin-2-yl)-2-methoxyacetamide; · N-(4-(1-(4-(3-(3-tert-butyl-1-p-tolyl-1-pyrazol-5-yl)ureido)naphthalen-1-yloxy)-2-methylpropan-2-yl)pyridin-2-yl)-2-methoxyacetamide;
Patent NZ-596877-A (NZ)
Title: Determining communication routes having shortest power line components in a power grid
Inventor: BUSH STEPHEN FRANCIS
IPC: G06F1/30
Filed: 2011-12-05
Abstract: Disclosed is a system for determining data communication routes for a power grid having a plurality of nodes. The system includes controllers (22) coupled to devices in an electrical power distribution network. The controllers (220) each include a communication identification module (220) that determines available wired and wireless modes of data transmission among the devices and a route availability identification module (224) for determining available routes using the available wired and wireless modes. The wired data transmission modes include communication links through power lines. The controllers (220) also each contain a route weight allocation module (226) that allocates a weight to each of the available routes. This allocation includes giving more weight to routes wired communication links that follow shortest electrical power lines than links that do not follow shortest electrical power lines. A route determination module (228), located in the controller (220), then determines a final route for data communications based on an objective function.
Patent NZ-597321-A (NZ)
Title: Application of conformal sub boundary layer vortex generators to a foil of aero / hydrodynamic surface
Inventor: IRELAND PETER S
IPC: F15D1/12
Filed: 2010-07-09
Abstract: A method of improving aerodynamic performance of foils by the application of conformal, low drag vortex generators. A film of erosion protection material or other conformal material is placed on the foil to provide a medium for the incorporation of planform edge vortex generators. The form edge is shaped to achieve submerged vortex generating shapes of chevron or ogival planforms, extending primarily chordwise on the foil surface. The vortex generators promote improved boundary layer dynamics by mixing free stream flow into the boundary layer while minimising separation and fluid losses. At the trailing edge, the shape formed with the chevrons applied apex forward, acts as a vented gurney tab series and additionally as disruptors to the Von Karman Street wake, delaying sheet roll up into the tip vortice.
Patent NZ-598476-A (NZ)
Title: Plantlet handling system
Inventor: TEASDALE ROBERT DIXON
IPC: A01G9/02
Filed: 2010-08-06
Abstract: There is provided plantlet handing apparatus including a housing (70) for a nutrient medium. A plurality of plantlet holders (72) each include a pair of body portions forming, in assembly, an open-topped container having apertures open to the nutrient medium in use. The body portions include engagement means engaging the body portions in assembly for handling and permitting separation. A plantlet holder support (71) is located in the housing and supports the plantlet holders in the nutrient medium while maintaining the body portions together. A closure (73) has a substantially airtight seal to the housing and has windows (111) of selected permeability to metabolic gases produced or required by plantlets.
Patent NZ-599070-A (NZ)
Title: Heterobicycle-substituted azolyl benzene fungicides
Inventor: TAGGI ANDREW EDMUND
IPC: A01N43/56
Filed: 2010-10-12
Abstract: Disclosed herein are heterobicycle-substituted azolyl benzene compounds of formula 1, wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and their use as fungicides. Examples of preferred compounds include: methyl N-[[2-chloro-5-[1-(3,4-dihydro-2HI-1-benzopyran-6-yl)-1H-pyrazol-3-yl]-phenyl]methyl]carbamate; methyl N-[[2-chloro-5-[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1H-pyrazol-1-yl]phenyl]methyl]carbamate; methyl N[[5-[3-(1,3-benzodioxol-5-yl)-1H-pyrazol-1-yl]-2-chlorophenyl]methyl]carbamate; methyl N-[[2-chloro-5-[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1H-pyrazol-1-yl]-phenyl]methyl]carbamate; methyl N-[[5-[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1H-pyrazol-1-yl]-2-fluorophenyl]methyl]carbamate.
Patent NZ-599921-A (NZ)
Title: Wheelchair
Inventor: YEE DANIEL JAMES
IPC: B61G5/00
Filed: 2010-11-15
Abstract: A wheelchair 100 comprising a frame. The frame comprises a j-shaped central frame member 202, where an arcuate portion of the j-shaped central frame member 202 is generally disposed in a downward direction. First and second caster support members 118, 120 are permanently fixed to and extend from the j-shaped central frame member 202. The caster support members 118, 120 collectively form a “V” or “U” shape that extends upwardly and away from the j-shaped central frame member 202. First and second drive wheel support members 114, 116 are permanently fixed to and extend from the j-shaped central frame member 202. The drive wheel support members collectively form a “V” or “U” shape that extends downward and away from the j-shaped central frame member 202. The j-shaped central frame member 202 is disposed substantially along a centreline of the wheelchair frame.
Patent NZ-601912-A (NZ)
Title: Removable barrier for location on an upper portion of a wall
Inventor: BRAZIS PAUL
IPC: E04G21/32
Filed: 2011-02-24
Abstract: 601912 A barrier device (10) for fixing to an upper portion of a wall is disclosed. The barrier device has fixing means (13) securable to the wall, and a barrier (11, 12) held by the fixing means that locates above the upper portion of the wall. The barrier is removable from the fixing means to allow access to the upper portion of the wall as required. In one aspect, at least a portion of the barrier (12) is moveable relative to a remainder of the barrier and between a first position where it is located above an upper edge of the wall, and a second position where access is then provided to the upper wall edge above which the movable barrier portion was previously positioned.
Patent NZ-618795-A (NZ)
Title: Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
Inventor: ALLEN SHELLEY
IPC: C07D495/04
Filed: 2012-05-09
Abstract: Compounds of Formula I: or stereoisomers, tautomers, or pharmaceutically acceptable salts, or solvates or prodrugs thereof, where R1, R2, Ra, Rb, Rc, Rd, X, Y, B, and Ring C are as defined herein, and wherein the Y-B moiety and the NH-C(=X)-NH moiety are in the trans configuration, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases. In one embodiment the compound is 1-((3S,4R)-4-(3,4-difluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(1-ethyl-5-methyl-3-phenyl-1H-pyrazol-4-yl)urea.
Patent NZ-623063-A (NZ)
Title: Antibacterial compounds and methods for use
Inventor: BRANSTROM ARTHUR
IPC: C07D471/04
Filed: 2012-08-29
Abstract: Provided are dihydropyridine derivative compounds of the general formula (I), wherein the variables are as defined in the specification. Examples of the compounds include 5-ethyl-6-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid and 5-ethyl-4-hydroxy-2-oxo-6-(1H-pyrrolo[2,3-b]pyridin-6-yl)-1,2-dihydropyridine-3-carboxylic acid. The compounds are antibacterial agents.
Patent NZ-627939-A (NZ)
Title: Apparatus for separating agricultural products
Inventor: BENEDETTI LUCA
IPC: B65G47/22
Filed: 2013-05-23
Abstract: An apparatus for severing fruits and vegetables at the stems is described. The apparatus maximises visual appeal of separated produce by using guides to cut stem at a desirable point and minimise damage to produce by using a grooved moving tray. Produce, e.g. cherries, are placed in the grooves of the tray (21, 22, 23..., Fig 2) and are picked up at the stem by the ramps (11-1, 12-1, 13-1....) to be severed by the respective cutters (11, 12, 13....). The series of blades and ramps are attached to a frame that allows for movement parallel to the grooves which aids in cutting the stems.
Patent NZ-706735-A (NZ)
Title: Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
Inventor: CAMERON BEATRICE
IPC: C12P21/08
Filed: 2008-08-27
Abstract: Disclosed is an isolated human or a humanized polypeptide that specifically binds to the extracellular domain of human CXCR5.
Patent NZ-719232-A (NZ)
Title: Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagonist and/or agonist of an immune checkpoint inhibitor
Inventor: DELCAYRE ALAIN
IPC: C07K16/28
Filed: 2014-10-31
Abstract: The present disclosure encompasses therapies, compositions, and methods for treatment of a human cancer patient using a recombinant poxvirus encoding a tumor-associated antigen in combination with one or more agonists or antagonists of immune checkpoint inhibitors. In a specific embodiment the medicament or composition comprises a recombinant orthopoxvirus comprising a nucleic acid encoding a polypeptide of a CEA antigen and a nucleic acid encoding a polypeptide of a MUC-1 antigen that is to be administered with an antagonist of PD-1 that is an antibody or an antagonist of LAG-3 that is an antibody.
Patent NZ-722727-A (NZ)
Title: 1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof
Inventor: LIU HONG
IPC: C07D451/04
Filed: 2014-12-29
Abstract: Provided are 1-(3-aminopropyl) substituted cyclic amine compounds as represented by formula (I), pharmaceutically acceptable salts, enantiomers, diastereoisomers, racemates and mixtures thereof, and a method of synthesizing said 1-(3-aminopropyl) substituted cyclic amine compounds by using aromatic heterocyclic formaldehyde as raw material. Said compounds can be used as CCR 5 antagonist for the treatment of HIV infection.
Patent NZ-724826-A (NZ)
Title: A high cell density fill and draw fermentation process
Inventor: LAUSTSEN MADS
IPC: C12M1/12
Filed: 2015-04-14
Abstract: The present invention relates to a high cell density fermentation fill and draw process for producing a product in a bioreactor system wherein during the fermentation, medium comprising impurities is removed via an impurity filter unit while new fresh medium is added to the cell culture vessel to replenish consumed nutrients and expelled medium. The addition of fresh medium and elimination of impurities provides the cells with the optimal environment to achieve high cell concentrations and thus higher productivity
Patent NZ-727046-A (NZ)
Title: Method for building a map of probability of one of absence and presence of obstacles for an autonomous robot
Inventor: GARCIA NICOLAS
IPC: G05D1/02
Filed: 2015-06-05
Abstract: There is a need for a humanoid robot capable of determining autonomously its localization and detecting threats and obstacles, without any intervention of a programmer. The present invention aims to overcome the limitations of the robots of the prior art by providing a robot capable of responding to this need with sufficient reliability to avoid collision, while being the least complex and CPU intensive. The invention relates to a method to compute a pixel map of probabilities of one of absence and presence of an obstacle in the environment of an autonomous robot. The autonomous robot comprises at least one sensor grouped in at least one set of sensors that detect obstacles of similar types and have its own sensor initial map of probability of absence of obstacles. The method comprises the steps of initializing, a plurality of initial maps around the robot and attached to the robot with a predefined value of probability of absence or presence of an obstacle, acquiring data representative of the absence or presence of an obstacle around the robot from at least one sensing procedure, and concurrently updating values of probabilities using data from sensing procedure and modifying the probabilities of absence or presence of obstacle from previous observations to a value closer to a predefined value and updating values of probabilities using data from sensing procedure.
Patent NZ-730949-A (NZ)
Title: Pulping liquors and uses thereof
Inventor: HUMPHREYS LEONARD
IPC: C10L1/00
Filed: 2015-10-15
Abstract: The present invention relates generally to the generation of bio-products from organic matter feedstocks. More specifically, the present invention relates to the use of pulping liquors in the hydrothermal/thermochemical conversion of lignocellulosic and/or fossilised organic feedstocks into biofuels (e.g. bio-oils) and/or chemical products (e.g. platform chemicals).
Patent NZ-732403-A (NZ)
Title: Air Conditioning System and Method for Leakage Detection in an Air Conditioning System
Inventor: SEBASTIAN HAERTIG
IPC: B60H1/00
Filed: 2017-06-01
Abstract: There is described an air conditioning system with a refrigerant circuit, wherein the air conditioning system includes a leakage detection system. The leakage detection system has a room temperature sensor, an inlet temperature sensor for detection of a refrigerant temperature at a refrigerant inlet of a refrigerant evaporator, and an outlet temperature sensor for detection of a refrigerant temperature at a refrigerant outlet of the refrigerant evaporator. The sensors are coupled with a calculating unit. The calculating unit is formed to calculate an outlet differential temperature as a difference of the room temperature and the refrigerant temperature at the refrigerant outlet and an evaporator differential temperature as a difference of the refrigerant temperature at the refrigerant inlet and at the refrigerant outlet, the outlet differential temperature and the evaporator differential temperature being used for leakage detection. In addition, there is described a method for leakage detection, in which a room temperature of the room to be air-conditioned is detected before the refrigerant evaporator on an air inlet side, a refrigerant inlet temperature is detected at the refrigerant inlet of a refrigerant evaporator, and a refrigerant outlet temperature is detected at a refrigerant outlet of the refrigerant evaporator.
Patent NZ-732547-A (NZ)
Title: Resin-coated metal sheet for can lids
Inventor: YAMANAKA YOICHIRO
IPC: B65D8/16
Filed: 2015-12-08
Abstract: A resin-coated metal sheet for a can lid is configured by: heat sealing a thermoplastic resin film A on a surface to be the exterior surface side of a can lid made of a metal sheet (1), the thermoplastic resin film A principally containing PBT and PET; and heat sealing a thermoplastic resin film B on a surface to be the interior surface side of the can lid, the thermoplastic resin film B principally containing PBT. In the thermoplastic resin film A, the PBT/PET composition ratio is (40/60)-(80/20) in terms of percentage by weight, and the ratio of the Raman band intensity (I0) at 1615 ±10 cm-1 in the horizontal plane of polarization with respect to the surface and the Raman band intensity (I90) at 1615±10 cm-1 in the vertical plane of polarization with respect to the surface is 0.60 or higher. The thermoplastic resin film (B) has a PET content of 95% (molar) or more. The melting point resulting from the PET in the thermoplastic resin film B is 250 to 265℃ and is at least 25℃ higher than the melting point resulting from the PBT in the thermoplastic resin film A. The half-value width of the Raman band at 1730±10 cm-1 in the horizontal plane with regard to the surface is 15-20 cm-1.
Patent NZ-739443-A (NZ)
Title: Cushion for patient interface
Inventor: HITCHCOCK ROBIN GARTH
IPC: A61M16/06
Filed: 2006-01-12
Abstract: Mask cushion including base wall structured to be connected to a frame and a membrane to form continuous seal on nasal bridge, cheek, and chin, with various parts of the membrane having various relatively stiffer or more flexible regions to accommodate various facial shapes.
Patent NZ-740630-A (NZ)
Title: Polymethine compounds and their use as fluorescent labels
Inventor: FRANCAIS ANTOINE
IPC: C07D209/08
Filed: 2016-09-26
Abstract: The present disclosure relates to new compounds of formula (I) and their use as fluorescent labels. The compounds may be used as fluorescent labels for nucleotides in nucleic acid sequencing applications.
Patent NZ-742682-A (NZ)
Title: Process of operating the air conditioning system of a cab of a machine
Inventor: GUERINEAU CHRISTOPHE
IPC: B60H1/00
Filed: 2016-11-24
Abstract: Existing air conditioning units when polluted air enters into the cab, for example upon opening of an access of the cab by the operator, are slow to evacuate the polluted air as the air provided by the air-conditioning system mainly comprises recycled air coming from the cab, i.e. potentially polluted air. Described is a process of operating the air conditioning system (5) of a cab (1 ) of a machine, the system comprising: a circuit (9) for supplying the cab with air coming from a recycling branch (9a) and an exterior branch (9b); a blowing device (10) for providing an air flow inside the circuit; filtration means (11, 11 a, 11 b, 15) in fluid communication with the exterior of the cab (1) and the exterior branch (9b) for removing pollutants from the air blown in the cab (1 ) through the circuit; the process comprising a regular procedure wherein the system (5) is operated to balance the air supplied by each of the branches (9a, 9b), the process comprising the monitoring of a signal indicative of a potential contamination of the cab (1 ) and, upon the detection of such signal, a flushing procedure wherein the system (5) is operated to: increase the flow of air supplied in the cab (1 ) by the blowing device (10) through the circuit (9); balance the flow of air to supply air coming only from the exterior branch (9b) by closing the recycling branch (9a); and open an exhaust flap (28) within the cab (1 ) for increasing the evacuated flow of air; the flushing procedure being performed for a determined period of time before performing again the regular procedure.
Patent PT-100313-A (PT)
Inventor: LAGARDE ALAIN E
IPC: A61K38/00
Filed: 1992-03-27
Abstract: Described is a purified osteogenic factor that when delivered to bone in association with a physiologically acceptable delivery vehicle is capable of inducing new bone growth at the bone surface. The osteogenic factor is water soluble, and is characterized physically by a molecular weight of about 2.5 kD when measured by gel filtration under dissociating conditions and an isoelectric point in the pH range from about 4.6 to 7.2. Use of the purified factor in treating bone defects is described. Also described is a method for obtaining the purified factor from mammalian bone.
Patent PT-101246-A (PT)
Title: Industrial prodn. of hydrogen@ - by reaction of lithium hydride with water
Inventor: RAMOS MARIA MARGARIDA PERESTRE
IPC: C01B3/00
Filed: 1993-03-31
Abstract: H2 is formed by reaction of Li hydride with sea water in presence of solar energy. The original Li hydride is regenerated from the Li hydroxide formed by an enzymatic reaction.
Patent PT-109272-A (PT)
Title: Central hidróeléctrica térmica em vácuo
Inventor: ANDRÉ JESUS DE CARVALHO PINTO
IPC: F24J3/08
Filed: 2016-04-04
Abstract: O PRESENTE INVENTO REFERE-SE A UMA CENTRAL QUE TRANSFORMA ENERGIA TÉRMICA EM ENERGIA ELÉTRICA, COMO CONSEQUÊNCIA PODE SERVIR TAMBÉM PARA AQUECIMENTO E REFRIGERAÇÃO. O SISTEMA DESTA CENTRAL É BASEADO NO CICLO DA ÁGUA, NO SEU INTERIOR O LÍQUIDO PASSA DO ESTADO LÍQUIDO A ESTADO GASOSO E VICE VERSA AO LONGO DO TEMPO DE FORMA CÍCLICA E SISTEMÁTICA EM CIRCUITO FECHADO. ESTAS TRANSFORMAÇÕES SÃO CONSEQUÊNCIA DE TROCAS TÉRMICAS COM UMA FONTE QUENTE OU FRIA, RESPETIVAMENTE ASSOCIADAS À SUA EVAPORAÇÃO NO EVAPORADOR (1) OU CONDENSAÇÃO NO CONDENSADOR (2). O SISTEMA TOMA PARTIDO DE UM GRANDE DESNÍVEL DE ALTITUDE ENTRE O CONDENSADOR (2) (NO TOPO) E O EVAPORADOR (1) (NA BASE), ESTE DESNÍVEL É USADO PARA PRODUÇÃO ELÉTRICA NO GRUPO COM VÁLVULA, TURBINA E GERADOR ELÉTRICO (6) E É TAMBÉM USADO PARA CRIAR VÁCUO NO INTERIOR DO SISTEMA COM A ABERTURA DAS VÁLVULAS (5), RETIRANDO DE FORMA NATURAL LÍQUIDO PARA O DEPÓSITO EXTERIOR (4). O GRUPO COM VÁLVULA, MOTOR A VAPOR E GERADOR ELÉTRICO (7) É USADO PARA INTERROMPER O SISTEMA E USAR A DIFERENÇA DE PRESSÃO PARA CRIAR ENERGIA ELÉTRICA. O SISTEMA PERMITE ARMAZENAMENTO DE ENERGIA NOS DEPÓSITOS INTERMÉDIOS (3), NO EVAPORADOR (1) E NO CONDENSADOR (2).